Clinicoserological factors associated with response to steroid treatment and recurrence in patients with IgG4-related ophthalmic disease

Abstract

Patients with IgG4-ROD responded well to systemic steroid treatment, but recurrence was common, particularly among those with elevated serum IgG4 levels and shorter duration of initial steroid treatment. Low-dose maintenance treatment with systemic steroids should be considered to avoid recurrence in patients with elevated serum IgG4 levels.